Ishin Co., Ltd.
Ishin Co., Ltd. (143A.T) Financial Performance & Income Statement Overview
Explore the financials of Ishin Co., Ltd. (143A.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Ishin Co., Ltd. (143A.T) Income Statement & Financial Overview
View the income breakdown for Ishin Co., Ltd. 143A.T across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $470.56M | $285.00M | $347.00M | $290.31M |
| Cost of Revenue | $124.39M | $66.00M | $79.00M | $60.48M |
| Gross Profit | $346.17M | $219.00M | $268.00M | $229.83M |
| Gross Profit Ratio | $0.74 | $0.77 | $0.77 | $0.79 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $205.24M | $203.00M | $199.00M | $210.73M |
| Operating Expenses | $205.24M | $202.00M | $200.00M | $210.73M |
| Total Costs & Expenses | $329.63M | $268.00M | $279.00M | $271.21M |
| Interest Income | $287000.00 | $4000.00 | $0.00 | $3000.00 |
| Interest Expense | $17000.00 | $18000.00 | $20000.00 | $20000.00 |
| Depreciation & Amortization | $2.36M | $3.25M | $2.00M | $2.36M |
| EBITDA | $133.84M | $19.25M | $71.00M | $20.16M |
| EBITDA Ratio | $0.28 | $0.07 | $0.20 | $0.07 |
| Operating Income | $140.93M | $17.00M | $68.00M | $19.10M |
| Operating Income Ratio | $0.30 | $0.06 | $0.20 | $0.07 |
| Other Income/Expenses (Net) | -$8.69M | $2.00M | -$4.00M | -$1.32M |
| Income Before Tax | $132.24M | $19.00M | $64.00M | $17.78M |
| Income Before Tax Ratio | $0.28 | $0.07 | $0.18 | $0.06 |
| Income Tax Expense | $48.91M | $5.00M | $28.00M | $7.00M |
| Net Income | $91.32M | $13.00M | $53.00M | $20.43M |
| Net Income Ratio | $0.19 | $0.05 | $0.15 | $0.07 |
| EPS | $47.48 | $6.61 | $26.91 | $10.78 |
| Diluted EPS | $47.17 | $6.76 | $26.76 | $10.78 |
| Weighted Avg Shares Outstanding | $1.93M | $1.97M | $1.92M | $1.90M |
| Weighted Avg Shares Outstanding (Diluted) | $1.93M | $1.92M | $1.94M | $1.90M |
Over the past four quarters, Ishin Co., Ltd. demonstrated steady revenue growth, increasing from $290.31M in Q1 2024 to $470.56M in Q4 2024. Operating income reached $140.93M in Q4 2024, maintaining a consistent 30% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $133.84M, reflecting operational efficiency. Net income rose to $91.32M, with EPS at $47.48. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan